Live Breaking News & Updates on Jeremy feffer

Stay informed with the latest breaking news from Jeremy feffer on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jeremy feffer and stay connected to the pulse of your community

NRx Pharmaceuticals Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

RADNOR - NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that the Company has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar...

Massachusetts , United-states , France , French , Jonathan-javitt , Matthew-duffy , Andrew-nierenberg , Jeremy-feffer , Exchange-commission , Nasdaq , Lotus-pharmaceuticals-inc , Lotus

Psyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Psyence Biomed Partners with Fluence and iNGENu CRO to Train Research Therapists for Phase IIb Psilocybin Trial
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Australia , United-states , American , Australian , Psyence-biomed , Veronika-simic , Neil-maresky , Jeremy-feffer , Elizabeth-nielson , National-association-of-social-workers , American-psychological-association , Nasdaq

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

MOUNTAIN VIEW, Calif., March 27, 2024 -- NeuroPace, Inc. , a medical device company focused on transforming the lives of people living with epilepsy, today announced it will present at the Needham...

Jeremy-feffer , Joel-becker , Nasdaq , Neuropace-inc , Globenewswire-inc , Annual-healthcare-conference , Chief-executive-officer , Markets ,

Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones

Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Toronto , Ontario , Canada , United-states , Australia , American , Jeremy-feffer , Psyence-biomed , Neil-maresky , Contract-research-organization , Instagram , Newcourt-acquisition-corp

Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study

NEW YORK, March 12, 2024 -- Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to...

Melbourne , Victoria , Australia , United-states , Canada , United-kingdom , Canadian , Australian , Jody-aufrichtig , Psyence-biomed , Neil-maresky , Jeremy-feffer

Psyence Group's NASDAQ Listed Associate, Psyence

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (

Australia , United-states , Canada , Melbourne , Victoria , United-kingdom , Canadian , Australian , Psyence-biomed , Neil-maresky , Jeremy-feffer , Jody-aufrichtig

NeuroPace, Inc.: NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

NeuroPace, Inc.: NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Martha-morrell , Jeremy-feffer , Stefan-klotter , Drug-administration , Nasdaq , Exchange-commission , Epilepsy-center , Neuropace-inc , Chief-medical , Comprehensive-epilepsy-center , Investigational-device-exemption

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

NAUTILUS is the first and only pivotal clinical study to evaluate neuromodulation therapy for treating drug refractory idiopathic generalized epilepsy Neuromodulation therapy is not currently...

United-states , Martha-morrell , Jeremy-feffer , Epilepsy-center , Globenewswire-inc , Nasdaq , Exchange-commission , Neuropace-inc , Drug-administration , Chief-medical , Comprehensive-epilepsy-center , Investigational-device-exemption

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 19, 2023 -- NeuroPace, Inc. , a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that its...

Mountain-view , California , United-states , San-francisco , Jeremy-feffer , Nasdaq , Neuropace-inc , Healthcare-conference , Markets ,

Leading Independent Proxy Advisory Firm ISS Recommends

Leading Independent Proxy Advisory Firm ISS Recommends
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Israel , Australia , Melbourne , Victoria , Irvine , California , United-states , Isfiya , H-efa , Jeremy-feffer , Institutional-shareholder-services-inc , Company-annual-report-on-form